An FDA advisory panel wants to get healthy people hooked on statin (cholesterol-lowering) drugs – with all their ugly side effects.
Yes, the FDA has reacted to a drug company-sponsored study showing that people with high C-reactive protein (CRP) levels had fewer heart attacks and strokes when taking statins.
But they brushed aside the 13 deaths and 18 “confused states” among the participants. And they ignored the increase in adult-onset diabetes as well.